Authors:
Asherson, P
Barr, C
Biederman, J
Buitelaar, J
Castellanos, X
Curran, S
Doyle, A
Ebstein, R
Eisenberg, J
Faraone, SV
Gill, M
Hay, D
Holmes, J
Hudziak, J
Kennedy, J
Kent, L
Levy, F
Manor, I
Mick, E
Price, T
Rohde, LA
Rowe, D
Sargeant, J
Simonoff, E
Spencer, T
Swanson, J
Taylor, E
Todd, R
Waldman, I
Yazgan, Y
Citation: P. Asherson et al., Report from the Second International Meeting of the Attention Deficit Hyperactivity Disorder Molecular Genetics Network, AM J MED G, 105(3), 2001, pp. 255-258
Authors:
Manor, I
Eisenberg, J
Tyano, S
Sever, Y
Cohen, H
Ebstein, RP
Kotler, M
Citation: I. Manor et al., Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder, AM J MED G, 105(1), 2001, pp. 91-95
Citation: J. Eisenberg, Management of hypertension - Guidelines do not consider workload implications in primary care, BR MED J, 320(7234), 2000, pp. 577-577
Authors:
Manor, I
Kotler, M
Sever, Y
Eisenberg, J
Cohen, H
Ebstein, RP
Tyano, S
Citation: I. Manor et al., Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort, AM J MED G, 96(6), 2000, pp. 858-860
Authors:
Eisenberg, J
Mei-Tal, G
Steinberg, A
Tartakovsky, E
Zohar, A
Gritsenko, I
Nemanov, L
Ebstein, RP
Citation: J. Eisenberg et al., Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. (vol 88,pg 497, 1999), AM J MED G, 96(6), 2000, pp. 893-893
Authors:
Asherson, P
Barkley, R
Barr, C
Berg, K
Biederman, J
Castellanos, X
Comings, D
Curran, S
Doyle, A
Ebstein, R
Eisenberg, J
Ergelen, E
Faraone, S
Freund, L
Geller, D
Gill, M
Holmes, J
Hudziak, J
Kennedy, J
Kent, L
Manor, I
Mick, E
Mitchell, H
Navia, B
Pato, C
Pato, M
Price, T
Sargeant, J
Simonoff, E
Smalley, S
Spencer, T
Swanson, J
Waldman, I
Wilens, T
Yazgan, Y
Citation: P. Asherson et al., Collaborative possibilities for molecular genetic studies of attention deficit hyperactivity disorder: Report from an international conference, AM J MED G, 96(3), 2000, pp. 251-257
Authors:
Eisenberg, J
Zohar, A
Mei-Tal, G
Steinberg, A
Tartakovsky, E
Gritsenko, I
Nemanov, L
Ebstein, RP
Citation: J. Eisenberg et al., A haplotype relative risk study of the dopamine D4 receptor (DRD4) Exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD), AM J MED G, 96(3), 2000, pp. 258-261
Authors:
Kotler, M
Manor, I
Sever, Y
Eisenberg, J
Cohen, H
Ebstein, RP
Tyano, S
Citation: M. Kotler et al., Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study, AM J MED G, 96(3), 2000, pp. 278-281
Authors:
Olivieri, A
Eisenberg, D
Soller, J
Eisenberg, J
Cooper, R
Tchobanoglous, G
Trussell, R
Gagliardo, P
Citation: A. Olivieri et al., Estimation of pathogen removal in an advanced water treatment facility using Monte Carlo simulation, WATER SCI T, 40(4-5), 1999, pp. 223-233
Authors:
Eisenberg, J
Mei-Tal, G
Steinberg, A
Tartakovsky, E
Zohar, A
Gritsenko, I
Nemanov, L
Ebstein, RP
Citation: J. Eisenberg et al., Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype, AM J MED G, 88(5), 1999, pp. 497-502
Authors:
Stanley, CW
Gottlieb, R
Zager, R
Eisenberg, J
Richmond, R
Moritz, MJ
Armenti, VT
Citation: Cw. Stanley et al., Developmental well-being in offspring of women receiving cyclosporine post-renal transplant, TRANSPLAN P, 31(1-2), 1999, pp. 241-242